Skip to main content
. 2021 Sep 29;65(5):617–624. doi: 10.20945/2359-3997000000399

Table 4. Pre- and post-treatment differences in patients.

Before testosterone treatment (n: 19) After testosterone treatment (n: 19) p Before hCG treatment (n: 17) After hCG treatment (n: 17) p
Total testosterone (ng/dL) 60 [86] 400 [234] <0.001 a 36 [31] 384 [220] <0.001 a
Estradiol (pg/mL) * 29.9 ± 2.2 29.5 ± 2.4 0.149 b 20.6 ± 2.5 40.8 ± 1.9 <0.001 b
Total testosterone to estradiol ratio ([ng/dL]/[pg/mL]) 1.8 [2.9] 13.3 [9] <0.00 a 1.6 [1.5] 9.1 [6] <0.00 a
Morning erections (≥3/week), (n, %) 0 (0%) 10 (58.8%) 0.002 a 0 (0%) 6 (35.3%) 0.014 a
Right Mean testicular volume (mL) 1.6 [2.5] 1.8 [2.2] 0.110 a 1.0 [5.8] 2.5 [6.5] <0.001 a
Left Mean testicular volume (mL) 1.6 [1.9] 1.8 [3.4] 0.008 a 1.1 [6.3] 2.8 [7.5] <0.001 a
Lumbar Z score -2.9 [1.2] -2.2 [0.9] <0.001 a -2.7 [1.5] -2.1 [0.7] <0.001 a

hCG: human chorionic gonadotropin.

a

Wilcoxon signed ranks test.

b

Paired samples t-test.

*

Data are presented as mean ± standard deviation (SD).

Data are presented as median (interquartile range [IQR]).